Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...

This week, Bobbi Conner talks with MUSC's Dr. Christina Mingora about the impact of recent advances in treating cystic ...

Transgenic ferret models ratted out how a rare cell type affects airway function. To determine whether these CFTR-rich cells are the lung’s airway traffic controllers, Engelhardt’s team developed ...

While many people with cystic fibrosis (CF) and COVID-19 have a mild to moderate illness, others are at a high risk of serious illness. This includes those who have a history of lung transplants or ...

Your body constantly renews your bone tissue in a process called bone turnover or bone remodeling. This process involves resorption (breaking down bone) and then reforming it. In people with cystic ...

The first drug that treats the root cause of cystic fibrosis won approval Tuesday, offering a life-changing treatment for a handful of patients with the deadly illness and broader hope for thousands ...

This clinical-stage biotech develops therapies targeting the root cause of cystic fibrosis, with a pipeline focused on CFTR ...

Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have ...

Add Yahoo as a preferred source to see more of our stories on Google. The genetic disorder cystic fibrosis is unique because it can cause both breathing and digestive problems. Some 40,000 people in ...